Clinical Trial Update: RTA 744 Injection in Patients With Leptomeningeal Disease [Phase 1]

View source ↗

Summary

Phase 1 trial of RTA 744 injection for leptomeningeal disease in patients with neoplastic meningitis and other CNS/solid tumors has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Leptomeningeal Metastasis
• Leukemia
• Lymphoma
• Solid Tumor

Drugs mentioned

• RTA 744

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Neoplastic Meningitis, Solid Tumor | Phase 1 | Status: TERMINATED